CLARITHROMYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Clarithromycin patents expire, and when can generic versions of Clarithromycin launch?
Clarithromycin is a drug marketed by Sandoz, Sun Pharm Inds Ltd, Actavis Labs Fl Inc, Ani Pharms, Dr Reddys Labs Sa, Lupin Ltd, Nostrum Labs Inc, Ranbaxy, Sunshine, Ajanta Pharma Ltd, Alembic, Aurobindo, Chartwell, Hec Pharm, Hikma, Ivax Sub Teva Pharms, Mylan, Strides Pharma, Teva, and Wockhardt. and is included in twenty-three NDAs.
The generic ingredient in CLARITHROMYCIN is clarithromycin. There are twenty-one drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the clarithromycin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clarithromycin
A generic version of CLARITHROMYCIN was approved as clarithromycin by ACTAVIS LABS FL INC on June 24th, 2004.
Summary for CLARITHROMYCIN
See drug prices for CLARITHROMYCIN
Recent Clinical Trials for CLARITHROMYCIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Minia University | N/A |
| Ain Shams University | N/A |
| TenNor Therapeutics (Suzhou) Limited | Phase 3 |
Pharmacology for CLARITHROMYCIN
| Drug Class | Macrolide Antimicrobial |
| Mechanism of Action | Cytochrome P450 3A Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
Medical Subject Heading (MeSH) Categories for CLARITHROMYCIN
Anatomical Therapeutic Chemical (ATC) Classes for CLARITHROMYCIN
US Patents and Regulatory Information for CLARITHROMYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065174-001 | Sep 24, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sandoz | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065144-001 | Oct 18, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sun Pharm Inds Ltd | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065174-002 | Sep 24, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sandoz | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065136-001 | Aug 25, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sandoz | CLARITHROMYCIN | clarithromycin | FOR SUSPENSION;ORAL | 065283-002 | Sep 4, 2007 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Chartwell | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065384-001 | Aug 20, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Ivax Sub Teva Pharms | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065137-001 | May 31, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
